Therefore, these SNPs would specifically affect the CCR5–MIP-1α interaction, and the genetic influence of these SNPs in MS or other autoimmune diseases would provide clues toward elucidating how the CCR5–MIP-1α interaction affects the progress of autoimmune diseases (Mahad et al. 2004). This evidence concerns the gene CCL3 and myeloid sarcoma.